دورية أكاديمية
The Power and Promise of Angiotensin Receptor Neprilysin Inhibitor (ARNI) in Heart Failure Management: National Consensus Statement.
| العنوان: | The Power and Promise of Angiotensin Receptor Neprilysin Inhibitor (ARNI) in Heart Failure Management: National Consensus Statement. |
|---|---|
| المؤلفون: | Chopra HK; Senior Consultant Cardiologist, Medanta Moolchand Heart Institute, Delhi., Wander GS; Professor & Head of Cardiology, Hero DMC Heart Institute, Dayanand Medical College & Hospital (DMCH), Ludhiana, Punjab., Ponde CK; Consultant Cardiologist and Head of Department, Department of Cardiology, P. D. Hinduja Hospital & Medical Research Centre, Mumbai, Maharashtra, India., Nanda NC; Professor of Medicine and Cardiovascular Disease, Heersink School of Medicine, University of Alabama at Birmingham (UAB), Birmingham, United Kingdom., Khullar D; Chairman, Department of Nephrology; Department of Kidney Transplant, Max Super Speciality Hospital, Delhi., Venugopal K; Professor Emeritus, Department of Cardiology, Pushpagiri Institute of Medical Sciences and Research Centre, Thiruvalla, Kerala., Ray S; Director, Department of Invasive Cardiology, AMRI Hospitals, Kolkata, West Bengal., Nair T; Head, Department of Cardiology & Interventional Cardiology, PRS Hospital, Trivandrum, Kerala., Rana DS; Emeritus Consultant Nephrologist, Department of Nephrology, Sir Ganga Ram Hospital., Kher V; Chairman; Department of Nephrology; Department of Kidney Transplant, Epitome Kidney Urology Institute & Lions Hospital., S Sawhney JP; Chairman, Department of Cardiology, Sir Ganga Ram Hospital, New Delhi, Delhi., Kasliwa RR; Adjunct Professor, Department of Cardiology; Chairman, Department of Clinical and Preventive Cardiology, Medanta Moolchand Heart Institute, Gurugram, Haryana., Jabir A; Senior Consultant Cardiologist, Lisie Hospital, Kochi, Kerala., Chakraborty R; Senior Vice Chairman and Head of Cardiology, Medica Superspecialty Hospital (MSH), Kolkata, West Bengal., Chandra P; Chairman, Department of Interventional Cardiology, Medanta Moolchand Heart Institute., Bansal S; Professor and HOD, Department of Cardiology, Safdarjung Hospital., Kumar V; Principal Director and Chief of Cath Lab, Department of Cardiac Sciences, Max Super Speciality Hospital, Delhi., Pancholia AK; HOD, Department of Medicine and Preventive Cardiology, Arihant Hospital & Research Centre, Indore, Madhya Pradesh., Kapoor A; Professor and Head of the Department, Department of Cardiology, Sanjay Gandhi Postgraduate Institute of Medical Sciences., Prakash S; Director and Head, Department of Nephrology; Department of Transplant service BLK, Max Super Speciality Hospital., Saxena A; Executive Director, Department of Cardiac Pacing and Electrophysiology, Fortis Escorts Heart Institute., Rastogi V; Director of Cardiology, Department of Cardiology, Fortis Escorts Heart Institute., Sharma V; Vice CEO and Head, Department of Cardiology, National Heart Institute., Arora YK; Cardiologist, National Heart Institute, Delhi., Dasbiswas A; Ex-Director, ICVS, Institute of Post Graduate Medical Education and Research (IPGME&R); Chief Cardiologist, Das Biswas Clinic, Kolkata, West Bengal., Bhargava M; Director, Department of Interventional Cardiology, Max Super Speciality Hospital, Delhi, India., Jaswal A; Member, Board of Directors, International Board of Heart Rhythm Examiners, Columbia, Washington, United States of America; Director, Department of Cardiac Pacing and Electrophysiology, Fortis Escorts Heart Institute., Bhargava K; Senior Director, Department of Cardiac Electrophysiology and Pacing, Medanta Moolchand Heart Institute., Bhatia M; Principal, Director, Head, Department of Imaging, Fortis Escorts Heart Institute., Omar AK; Director, Head, Department of Non-Invasive Cardiology, Fortis Escorts Heart Institute., Khanna NN; Advisor, Senior Consultant, Department of Cardiology, Indraprastha Apollo Hospitals., Passey R; Consultant Cardiologist, Sir Ganga Ram Hospital., Bhalla D; Senior Director, Department of Nephrology and Renal Transplant, Max Super Speciality Hospital, Delhi., Vijayalakshmi IB; Professor Emeritus, Former HOD, Department of Paediatric Cardiology, Sri Jayadeva Institute of Cardiovascular Sciences and Research, Bengaluru, Karnataka., Bhalla AK; Chairman, Department of Nephrology, Sir Ganga Ram Hospital, Delhi., Moorthy A; Senior Consultant Cardiologist, SIMS Hospital, Chennai, Tamil Nadu., Isser HS; Department of Cardiology, VMMC & Safdarjung Hospital., Mishra SS; Cardiologist, Med N Heart Clinic, Delhi., Routray SN; Professor, Department of Cardiology, Srirama Chandra Bhanj Medical College & Hospital (S.C.B Medical College), Cuttack, Odisha., Tandon V; Associate Director, In charge, Non-Invasive Cardiac Laboratory, Max Smart Super Speciality Hospital, Delhi., Sinha A; Senior Consultant, Cardiologist, Jay Prabha Medanta Super Specialty Hospital, Patna, Bihar., Bansal M; Senior Director, Department Clinical and Preventive Cardiology, Medanta - The Medicity Multi-Speciality Hospital, Gurugram, Haryana., Jain P; Executive Director, Chief Cardiologist, Lifeline Superspeciality Hospital and Heart Center, Jhansi, Uttar Pradesh., Hotchandani R; Consultant, Head, Department of Nephrology, Moolchand Centre for Renal Care and Dialysis, Moolchand Hospital, Delhi., Jain D; Professor, Department of Cardiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh., Katyal VK; HOD, Department of General Medicine, Positron Hospital; Formerly Senior Professor, HOD, Department of Medicine, Pt. B.D.Sharma, Post Graduate Institute of Medical Sciences, Rohtak, Haryana., Gulati S; Principal Director, Department of Nephrology, Fortis Hospital, Delhi., Tandon R; Senior Consultant Physician, Department of Cardiology, Hero DMC Heart Institute, Dayanand Medical College & Hospital (DMCH), Ludhiana, Punjab., Jaggi S; Director, Consultant Diabetologist, Lifecare Diabetes Centre., Sehgal B; Consultant Nephrologist, Department of Nephrology, Sri Balaji Action Medical Institute, Delhi., Gupta V; Honorary Teaching Faculty, All India Institute of Medical Sciences; Consultant Physician, Kishori Ram Hospital, Bathinda, Punjab., Mehrotra R; Director and Head, Department of Non-Invasive Cardiology, Max Super Speciality Hospital., Krishnamani NC; Department of Cardiac Sciences,Fortis Healthcare Limited., Pathak SN; Senior Consultant Interventional Cardiologist, Indraprastha Apollo Hospital., Yadav MS; Senior Consultant, Department of Interventional Cardiology, Max Super Speciality Hospital., Chawla R; Senior Consultant Diabetologist, Director, North Delhi Diabetes Centre, Delhi., Pal J; Professor, Department of General Medicine, R.G. Kar Medical College & Hospital., Chatterjee N; Clinical Pharmacologist, Diabetes & Allergy-Asthma Therapeutics Specialty Clinic., Samajdar SS; Professor, Department of Medicine, Institute of Post Graduate Medical Education and Research (IPGME&R) - SSKM Hospital., Shastry NR; Cardiologist, Department of Clinical Cardiology, Medanta-Moolchand Heart Centre, Delhi, India. |
| المصدر: | The Journal of the Association of Physicians of India [J Assoc Physicians India] 2023 Feb; Vol. 71 (2), pp. 11-12. |
| نوع المنشور: | Review; Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Association of Physicians of India Country of Publication: India NLM ID: 7505585 Publication Model: Print Cited Medium: Print ISSN: 0004-5772 (Print) Linking ISSN: 00045772 NLM ISO Abbreviation: J Assoc Physicians India Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Bombay : Association of Physicians of India Original Publication: Bombay [1953?]- |
| مواضيع طبية MeSH: | Heart Failure*/drug therapy, Humans ; Neprilysin/pharmacology ; Stroke Volume/physiology ; Tetrazoles/therapeutic use ; Tetrazoles/pharmacology ; Quality of Life ; Ventricular Function, Left ; Angiotensin Receptor Antagonists/therapeutic use ; Angiotensin Receptor Antagonists/pharmacology ; Treatment Outcome ; Antihypertensive Agents/therapeutic use ; Drug Combinations |
| مستخلص: | ;Heart failure (HF) is a huge global public health task due to morbidity, mortality, disturbed quality of life, and major economic burden. It is an area of active research and newer treatment strategies are evolving. Recently angiotensin receptor-neprilysin inhibitor (ARNI), a class of drugs (the first agent in this class, Sacubitril-Valsartan), reduces cardiovascular mortality and morbidity in chronic HF patients with reduced left ventricular ejection fraction (LVEF). Positive therapeutic effects have led to a decrease in cardiovascular mortality and HF hospitalizations (HFH), with a favorable safety profile, and have been documented in several clinical studies with an unquestionable survival benefit with ARNI, Sacubitril-Valsartan. This consensus statement of the Indian group of experts in cardiology, nephrology, and diabetes provides a comprehensive review of the power and promise of ARNI in HF management and an evidence-based appraisal of the use of ARNI as an essential treatment strategy for HF patients in clinical practice. Consensus in this review favors an early utility of Sacubitril-Valsartan in patients with HF with reduced EF (HFrEF), regardless of the previous therapy being given. A lower rate of hospitalizations for HF with Sacubitril-Valsartan in HF patients with preserved EF who are phenotypically heterogeneous suggests possible benefits of ARNI in patients having 40-50% of LVEF, frequent subtle systolic dysfunction, and higher hospitalization risk. (© Journal of the Association of Physicians of India 2011.) |
| المشرفين على المادة: | EC 3.4.24.11 (Neprilysin) 0 (Tetrazoles) 0 (Angiotensin Receptor Antagonists) 0 (Antihypertensive Agents) 0 (Drug Combinations) |
| تواريخ الأحداث: | Date Created: 20230624 Date Completed: 20230626 Latest Revision: 20230626 |
| رمز التحديث: | 20230626 |
| DOI: | 10.5005/japi-11001-0209 |
| PMID: | 37354473 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 0004-5772 |
|---|---|
| DOI: | 10.5005/japi-11001-0209 |